ESSENTIAL HYPERTENSION
Clinical trials for ESSENTIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new ESSENTIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for ESSENTIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hypertension drug enters phase 2 testing
Disease control Not yet recruitingThis study tests five different doses of a new drug called BR1400 in 330 adults with high blood pressure (essential hypertension). The goal is to see how well each dose lowers blood pressure and how safe it is over 8 weeks. Participants must have a certain blood pressure range an…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 26, 2026 06:17 UTC
-
Zapping the brain to lower blood pressure? new trial explores a needle-free approach.
Disease control Not yet recruitingThis study tests whether a gentle, non-invasive brain stimulation technique called temporal interference stimulation can safely lower blood pressure in people with mild essential hypertension. Sixty adults aged 30-65 who are not currently on blood pressure medication will receive…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated May 26, 2026 06:07 UTC
-
Blood pressure breakthrough: lifestyle program aims to free patients from pills
Disease control Not yet recruitingThis study tests whether a 12-week program of diet, exercise, sleep, and stress management, combined with a careful plan to reduce blood pressure medication, can help people with high blood pressure achieve remission. The goal is to see if participants can safely stop all blood p…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: NA • Sponsor: Evelyn Vanina Re • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Healthy volunteers needed to test new blood pressure pill combo
Knowledge-focused Not yet recruitingThis early-stage study will test a new drug combination for high blood pressure in 58 healthy adults. Participants will take the drugs by mouth after fasting, and researchers will measure drug levels in the blood to see how the body absorbs and processes them. The goal is to gath…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 26, 2026 06:08 UTC
-
Healthy volunteers to test new blood pressure combo pill
Knowledge-focused Not yet recruitingThis early-stage study will give a single dose of a new blood pressure medication (BR1015) to 58 healthy adults. Researchers want to measure how the drug moves through the body and check for side effects. Participants must not have high blood pressure themselves. The goal is to g…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 26, 2026 05:49 UTC
-
Healthy volunteers needed for blood pressure drug combo test
Knowledge-focused Not yet recruitingThis early-stage study tests how two blood pressure medicines (BR1015-3 and BR1015-2) work when taken together compared to a combined pill. It involves 48 healthy adults and measures drug levels and safety. No treatment is given for high blood pressure—this is just to gather info…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
New blood pressure combo tested in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a new combination of drugs for high blood pressure in 48 healthy adults. The goal is to see how the body absorbs and handles the drugs and to check for any safety issues. Participants will take the drugs by mouth after eating, and the study will compa…
Matched conditions: ESSENTIAL HYPERTENSION
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC